CCT starts debate on medication identification


Source: Agência Senado, 11/06/2008

The Commission for Science, Technology, Innovation, Communication and Informatics (CCT) has just started the public hearing to instruct the bill authored by Senator Valdir Raupp (PMDB-RO), which determines the mandatory identification of medicines through of electronic system (PLS 521/07). The requirement for the debate is Senators Marcelo Crivella (PRB-RJ) and Wellington Salgado (PMDB-MG).


Five experts were invited to discuss the matter: the director-president of the Association of National Pharmaceutical Laboratories (Alanac), Carlos Alexandre Geyer; the Executive Regulatory Technical Director of the Brazilian Federation of the Pharmaceutical Industry, Lauro Moretto; the manager of economic affairs, foreign trade and information technology at the Association of the Pharmaceutical Research Industry (Interfarma), Marcelo Liebhardt; the director-president of the National Health Surveillance Agency (Anvisa), Dirceu Raposo de Mello, and the president of the Brazilian Institute of Ethics in Competition (ETCO), André Franco Montoro Filho.



See also:

 CCT holds public hearing to debate electronic drug identification

 Health experts agree that increased enforcement is the best way to combat counterfeit drugs